Skye Bioscience, Inc. (SKYE)
0.7443
+0.02
(+2.38%)
USD |
NASDAQ |
Dec 31, 16:00
0.7443
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Market Cap: 23.86M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 204.06M |
| Theravance Biopharma, Inc. | 947.32M |
| Viking Therapeutics, Inc. | 3.974B |
| FibroGen, Inc. | 35.08M |
| Myomo, Inc. | 35.70M |
Market Cap Related Metrics
| PEG Ratio | -0.0109 |
| Price to Book Value | 0.7267 |
| Price | 0.7443 |
| Earnings Yield | -173.3% |
| PEGY Ratio | -0.0109 |